Thekiwi
Active Member
v10 does look like a very good advacnement, but in the limited amount of beta test videos I have seen online I have already seen close calls where FSD was trying to turn into fast moving oncoming traffic with only a last second disengagement by the driver avoiding a serious crash.It’s not a very big question. It’s not even a tiny question. Answer: Somebody dies and most likely because they didn’t take the necessary caution and attention required to drive with (or without) FSD engaged. In other words, they didn’t value their lives enough nor those around them.
It behooves all people to get out of their fearmongering state. If you can’t, then give into your fear and hedge by selling your TSLA stock. And don’t get irritated because I just gave you the solution to your fear.
If you think regulators are going to rely on logical thought and statistics when FSD causes a fatality event that is judged to have been impossible for the human monitor to prevent, then I have a bridge to sell you.
It is a very real possibility that when it occurs that Tesla will have to indeed remove the FSD beta program, and move to an internal testing program where testers are employed by Tesla. I don’t think that would be a big detriment to FSD development, with the result being a small relative rise in R&D costs. I’m not saying it’s a definite, but investors shouldn’t be downplaying this outcome.
Regardless of whether or not regulators end up shutting down the public FSD beta program after a FSD fatality, it is going to be a MASSIVE media event and will be one of the most challenging times for the Tesla brand. It will not be viewed as a Tesla driver killing someone, but instead tesla’s software. For most companies, beta testing a product in public that ends up killing people is a bad thing.
I have no intention of selling my shares and am still in accumulation mode, but I am very prepared for the inevitable poopstorm of negative headlines the rapidly approaching FSD beta program will no doubt produce.
I think many are underestimating the required level cost/benefit ratio for FSD in terms of human lives lost for it to be acceptable to regulators. It’s probably higher than 10:1, and maybe closer to 100:1.
Think of it this way: how many deaths from side effects are judged as acceptable when regulators are evaluating new medications/therapies?
Last edited: